This report aims to educate Pharmacy500 professionals, pharmacy leaders, and industry stakeholders on the 503B compounding sector and its critical role in healthcare. 503B outsourcing facilities, regulated by the FDA, produce large quantities of sterile and non-sterile compounded medications to help address drug shortages and support clinical needs. By ensuring safety, compliance, and reliability, these facilities strengthen medication access and continuity of care across the healthcare system.
